Cubist Systematic Strategies’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,830
| Closed | -$232K | – | 1435 |
|
|
2024
Q1 | $232K | Sell |
22,830
-122,155
| -84% | -$1.24M | ﹤0.01% | 1624 |
|
|
2023
Q4 | $1.63M | Buy |
144,985
+98,832
| +214% | +$1.11M | 0.01% | 909 |
|
|
2023
Q3 | $120K | Sell |
46,153
-102,249
| -69% | -$266K | ﹤0.01% | 1612 |
|
|
2023
Q2 | $524K | Buy |
148,402
+48,934
| +49% | +$173K | ﹤0.01% | 1394 |
|
|
2023
Q1 | $420K | Buy |
+99,468
| New | +$420K | ﹤0.01% | 1886 |
|
|
2022
Q4 | – | Sell |
-170,947
| Closed | -$2.18M | – | 3244 |
|
|
2022
Q3 | $2.18M | Buy |
170,947
+71,582
| +72% | +$914K | 0.01% | 1513 |
|
|
2022
Q2 | $1.16M | Buy |
99,365
+9,880
| +11% | +$116K | 0.01% | 2010 |
|
|
2022
Q1 | $545K | Sell |
89,485
-1,906
| -2% | -$11.6K | ﹤0.01% | 2465 |
|
|
2021
Q4 | $837K | Buy |
+91,391
| New | +$837K | 0.01% | 2052 |
|
|
2021
Q3 | – | Sell |
-69,300
| Closed | -$683K | – | 2942 |
|
|
2021
Q2 | $683K | Sell |
69,300
-60,917
| -47% | -$600K | 0.01% | 1803 |
|
|
2021
Q1 | $1.84M | Buy |
130,217
+56,117
| +76% | +$793K | 0.02% | 1093 |
|
|
2020
Q4 | $836K | Buy |
74,100
+618
| +0.8% | +$6.97K | 0.01% | 1494 |
|
|
2020
Q3 | $970K | Buy |
+73,482
| New | +$970K | 0.01% | 1354 |
|
|
2017
Q1 | – | Sell |
-104
| Closed | -$102K | – | 1611 |
|
|
2016
Q4 | $102K | Buy |
+104
| New | +$102K | 0.01% | 1478 |
|